EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lung NETs and GEPNETs: One Cancer with Different Origins or Two Distinct Cancers?

Georgios Evangelou iD, Ioannis Vamvakaris, Anastasia Papafili, Maximilian Anagnostakis iD, Melpomeni Peppa

Cancers · 17.03.2024 · 16 (6) · 1177

DOI: 10.3390/cancers16061177 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.03.2024. Verfasst von Georgios Evangelou und 4 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Medicine, National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung neuroendocrine tumors (LNETs) and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are two distinct types of neuroendocrine tumors (NETs) that have traditionally been treated as a single entity despite originating from different sources. Although they share certain phenotypic characteristics and the expression of neuroendocrine markers, they exhibit differences in their microenvironment, molecular mutations, and responses to various therapeutic regimens. Recent research has explored the genetic alterations in these tumors, revealing dissimilarities in the frequently mutated genes, the role of EGFR in carcinogenesis, the presence of transcription factors, and the immunogenicity of the tumor and its microenvironment. Spread Through Air Spaces (STAS), a phenomenon unique to lung carcinomas, appears to play a crucial role in LNET prognosis. These distinctions are also evident in the cascade response of lung and GI tract neuroendocrine tumors to somatostatin analogs, Peptide Receptor Radionuclide Therapy (PRRT), chemotherapy, and immunotherapy. Identifying similarities and differences between the two groups may improve our understanding of the underlying mechanisms and facilitate the development of more effective treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

DLL3EGFRatypical carcinoidimmunotherapylung NETsneuroendocrine tumorspulmonary NETstypical carcinoid

Autor:innen und Institutionen

  • 3rd Department of Medicine, National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece.
  • Department of Pathology, Sotiria Chest Diseases Hospital, 11527 Athens, Greece.
  • Department of Oncology, Iatriko Kentro Athinon Marousi, 15125 Athens, Greece.
  • Endocrine Unit, 2nd Propaedeutic Department of Internal Medicine, Research Institute and Diabetes Center, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12461 Athens, Gr…
  • 3rd Department of Internal Medicine, Sotiria General Hospital, 11527 Athens, Greece.

ORCID-Profile: Georgios Evangelou, Maximilian Anagnostakis

Zitieren

APA

Evangelou, G., Vamvakaris, I., Papafili, A., Anagnostakis, M., & Peppa, M. (2024). Lung NETs and GEPNETs: One Cancer with Different Origins or Two Distinct Cancers?. Cancers, 16(6), 1177. https://doi.org/10.3390/cancers16061177

Vancouver

Evangelou G, Vamvakaris I, Papafili A, Anagnostakis M, Peppa M. Lung NETs and GEPNETs: One Cancer with Different Origins or Two Distinct Cancers?. Cancers. 2024;16(6):1177. doi:10.3390/cancers16061177

BibTeX
@article{Evangelou2024,
  author = {Evangelou, Georgios and Vamvakaris, Ioannis and Papafili, Anastasia and Anagnostakis, Maximilian and Peppa, Melpomeni},
  title = {Lung NETs and GEPNETs: One Cancer with Different Origins or Two Distinct Cancers?},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {6},
  pages = {1177},
  doi = {10.3390/cancers16061177}
}
Kostenlos starten →